Experimental ASXL1‐Mediated Clonal Hematopoiesis Promotes Inflammation and Accelerates Heart Failure

Experimental ASXL1‐Mediated Clonal Hematopoiesis Promotes Inflammation and Accelerates Heart Failure

Bibliographic Details
Main Authors:	Kyung‐Duk Min, Ariel H. Polizio, Anupreet Kour, Mark C. Thel, Kenneth Walsh
Format:	Article
Language:	English
Published:	Wiley 2022-10-01
Series:	Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:	aged aging cardiovascular diseases cause of death clonal hematopoiesis stroke volume
Online Access:	https://www.ahajournals.org/doi/10.1161/JAHA.122.026154

Similar Items

Longitudinal profiling of clonal hematopoiesis provides insight into clonal dynamics
by: Md Mesbah Uddin, et al.
Published: (2022-05-01)

Measures of Clonal Hematopoiesis: Are We Missing Something?
by: Leonid V. Bystrykh, et al.
Published: (2022-03-01)

Molecular Pathways in Clonal Hematopoiesis: From the Acquisition of Somatic Mutations to Transformation into Hematologic Neoplasm
by: Charles Gaulin, et al.
Published: (2022-07-01)

Chicken or Egg: Is Clonal Hematopoiesis Primarily Caused by Genetic or Epigenetic Aberrations?
by: Olivia Cypris, et al.
Published: (2019-09-01)

Clonal hematopoiesis of indeterminate potential: clinical relevance of an incidental finding in liquid profiling
by: Hoermann Gregor
Published: (2022-08-01)

New approaches to idiopathic neutropenia in the era of clonal hematopoiesis
by: Olisaemeka D. Ogbue, et al.
Published: (2023-04-01)

Association of Clonal Hematopoiesis of Indeterminate Potential with Inflammatory Gene Expression in Patients with COPD
by: Stefan Kuhnert, et al.
Published: (2022-07-01)

Common in atherogenesis and carcinogenesis: clonal hematopoiesis
by: A. A. Sleptsov, et al.
Published: (2023-11-01)

Cancer patients with clonal hematopoiesis die from primary malignancy or comorbidities despite higher rates of transformation to myeloid neoplasms
by: Kelly S. Chien, et al.
Published: (2024-03-01)

Evaluation of clonal hematopoiesis and mosaic loss of Y chromosome in cardiovascular risk: An analysis in prospective studies
by: Sami Fawaz, et al.
Published: (2024-12-01)

Clonal hematopoiesis and inflammation: a link with thrombosis and malignancy
by: Tiziano Barbui
Published: (2022-07-01)

Clonal hematopoiesis and acute myeloid leukemia
by: A. I. Kashlakova, et al.
Published: (2023-09-01)

Clonal hematopoiesis of indeterminate potential and heart failure
by: E. A. Lyasnikova, et al.
Published: (2024-12-01)

Clonal hematopoiesis as a novel risk factor for type 2 diabetes mellitus in patients with hypercholesterolemia
by: Min Joo Kim, et al.
Published: (2023-06-01)

Investigation of the impact of clonal hematopoiesis on severity and pathophysiology of COVID-19 in rhesus macaques
by: Tae-Hoon Shin, et al.
Published: (2023-07-01)

Aging-elevated inflammation promotes DNMT3A R878H-driven clonal hematopoiesis
by: Min Liao, et al.
Published: (2022-02-01)

Clonal hematopoiesis of indeterminate potential is associated with increased risk of immune checkpoint inhibitor myocarditis in a prospective study of a cardio-oncology cohort
by: Rachel Jaber Chehayeb, et al.
Published: (2024-11-01)

Clonal abundance patterns in hematopoiesis: Mathematical modeling and parameter estimation
by: Yunbei Pan, et al.
Published: (2023-02-01)

Roles of JAK2 in Aging, Inflammation, Hematopoiesis and Malignant Transformation
by: Florian Perner, et al.
Published: (2019-08-01)

The Presence of Clonal Hematopoiesis Is Negatively Associated with Diabetic Peripheral Neuropathy in Type 2 Diabetes
by: Tae Jung Oh, et al.
Published: (2022-04-01)

Association Between Clonal Hematopoiesis Driver Mutations, Immune Cell Function, and the Vasculometabolic Complications of Obesity
by: Helin Tercan, et al.
Published: (2024-01-01)

Clonal Hematopoiesis and Liquid Biopsy in Gastrointestinal Cancers
by: Vlad M. Croitoru, et al.
Published: (2022-01-01)

Human Immunodeficiency Virus and Clonal Hematopoiesis
by: Stamatia C. Vorri, et al.
Published: (2023-02-01)

Cutaneous Langerhans cell histiocytosis and other systemic inflammatory or autoimmune disease manifestations in the setting of clonal hematopoiesis
by: Giby V. George, et al.
Published: (2024-10-01)

Clonal hematopoiesis of indeterminate potential and the risk of pulmonary embolism: an observational studyResearch in context
by: Qianwei Liu, et al.
Published: (2024-08-01)

Cellular heterogeneity and clonal hematopoiesis of immune system cells in atherosclerosis
by: A. A. Sleptsov
Published: (2022-11-01)

Clonal Hematopoiesis Is Associated With Long‐Term Adverse Outcomes Following Cardiac Surgery
by: Sandro Ninni, et al.
Published: (2024-09-01)

Fatal Progression of Mutated TP53-Associated Clonal Hematopoiesis following Anti-CD19 CAR-T Cell Therapy
by: Lea Naomi Eder, et al.
Published: (2023-01-01)

From Clonal Hematopoiesis to Therapy-Related Myeloid Neoplasms: The Silent Way of Cancer Progression
by: Carmelo Gurnari, et al.
Published: (2021-02-01)

Clonal Hematopoiesis of Indeterminate Potential From a Heart Failure Specialist's Point of View
by: Maurits A. Sikking, et al.
Published: (2023-08-01)

Low Impact of Clonal Hematopoiesis on the Determination of RAS Mutations by Cell-Free DNA Testing in Routine Clinical Diagnostics
by: Cristin Roma, et al.
Published: (2022-08-01)

Increased inflammatory signature in myeloid cells of non-small cell lung cancer patients with high clonal hematopoiesis burden
by: Hyungtai Sim, et al.
Published: (2024-12-01)

Association between clonal hematopoiesis-related gene mutations and unfavorable functional outcome in patients with large-artery atherosclerotic stroke
by: Xin Qiu, et al.
Published: (2023-12-01)

Birth Weight Is Associated With Clonal Hematopoiesis of Indeterminate Potential and Cardiovascular Outcomes in Adulthood
by: Art Schuermans, et al.
Published: (2023-07-01)

Clinical Significance of Clonal Hematopoiesis of Indeterminate Potential in Hematology and Cardiovascular Disease
by: Gregor Hoermann
Published: (2022-07-01)

Genetic evidence for the causal effect of clonal hematopoiesis on pulmonary arterial hypertension
by: Jia-Yong Qiu, et al.
Published: (2025-01-01)

Obesity and Clonal Hematopoiesis of Indeterminate Potential: Allies in Cardiovascular Diseases and Malignancies
by: Luka Komic, et al.
Published: (2023-06-01)

Case Report: First longitudinal study of a patient with CALR positive clonal hematopoiesis of indeterminate potential developing into pre-fibrotic myelofibrosis
by: Lasse Kjær, et al.
Published: (2023-05-01)

Clonal hematopoiesis of indeterminate potential (CHIP) and cardiovascular diseases—an updated systematic review
by: Nagendra Boopathy Senguttuvan, et al.
Published: (2021-07-01)

Exploring the Impact of Clonal Hematopoiesis on Heart Failure and Remodeling in Aortic Stenosis
by: Minkwan Kim, MD, PhD
Published: (2025-02-01)